Page last updated: 2024-08-24

gemcitabine and gw8510

gemcitabine has been researched along with gw8510 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chen, CG; Chen, K; Chen, P; Jiang, HG; Lan, T; Li, J; Qian, H; Shu, Y; Wu, JN; Zhao, XH	1
Ak, H; Atay, S; Aydin, HH; Rüstem, DG	1

Other Studies

2 other study(ies) available for gemcitabine and gw8510

Article	Year
Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction. Clinical science (London, England : 1979), 2018, 07-16, Volume: 132, Issue:13 Topics: Animals; Antimetabolites, Antineoplastic; Autophagy; Carcinoma, Squamous Cell; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Indoles; Lung Neoplasms; Male; Mice, Inbred NOD; Ribonucleoside Diphosphate Reductase; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2018
Synergistic Interactions between GW8510 and Gemcitabine in an In Vitro Model of Pancreatic Cancer. Anti-cancer agents in medicinal chemistry, 2021, 10-28, Volume: 21, Issue:16 Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Cell Survival; Computational Biology; Deoxycytidine; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Indoles; Pancreatic Neoplasms; Ribonucleoside Diphosphate Reductase; Tumor Cells, Cultured	2021

Article

Year

Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction.

Clinical science (London, England : 1979), 2018, 07-16, Volume: 132, Issue:13

Topics: Animals; Antimetabolites, Antineoplastic; Autophagy; Carcinoma, Squamous Cell; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Indoles; Lung Neoplasms; Male; Mice, Inbred NOD; Ribonucleoside Diphosphate Reductase; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018

Synergistic Interactions between GW8510 and Gemcitabine in an In Vitro Model of Pancreatic Cancer.

Anti-cancer agents in medicinal chemistry, 2021, 10-28, Volume: 21, Issue:16

Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Cell Survival; Computational Biology; Deoxycytidine; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Indoles; Pancreatic Neoplasms; Ribonucleoside Diphosphate Reductase; Tumor Cells, Cultured

2021